← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

AMWL logoAmerican Well Corporation(AMWL)Earnings, Financials & Key Ratios

AMWL•NYSE
$7.15
$119M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryVirtual Care and Digital Programs
AboutAmerican Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.Show more
  • Revenue$249M-2.0%
  • EBITDA-$71M+61.4%
  • Net Income-$96M+54.0%
  • EPS (Diluted)-5.96+57.1%
  • Gross Margin53.29%+37.0%
  • EBITDA Margin-28.6%+60.6%
  • Operating Margin-42.22%+50.6%
  • Net Margin-38.38%+53.1%
  • ROE-33.93%+35.1%
  • ROIC-95.06%+37.1%
  • Debt/Equity0.02-29.6%
Technical→

AMWL Key Insights

American Well Corporation (AMWL) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Strong 5Y profit CAGR of 15.7%
  • ✓Trading at only 0.5x book value

✗Weaknesses

  • ✗Negative free cash flow

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

AMWL Price & Volume

American Well Corporation (AMWL) stock price & volume — 10-year historical chart

Loading chart...

AMWL Growth Metrics

American Well Corporation (AMWL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years0.33%
3 Years-3.47%
TTM-30.26%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM43.21%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM46.81%

Return on Capital

10 Years-34.78%
5 Years-42.62%
3 Years-58.72%
Last Year-36.6%

AMWL Recent Earnings

American Well Corporation (AMWL) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 5, 2026
EPS
$0.66
Est $0.77
+14.3%
Revenue
$55M
Est $52M
+6.5%
Q1 2026
Feb 12, 2026
EPS
$1.43
Est $1.59
+10.1%
Revenue
$55M
Est $53M
+5.1%
Q4 2025
Nov 4, 2025
EPS
$1.74
Est $1.46
-19.4%
Revenue
$56M
Est $55M
+3.2%
Q3 2025
Aug 5, 2025
EPS
$1.24
Est $1.84
+32.6%
Revenue
$71M
Est $61M
+15.4%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.66vs $0.77+14.3%
$55Mvs $52M+6.5%
Q1 2026Feb 12, 2026
$1.43vs $1.59+10.1%
$55Mvs $53M+5.1%
Q4 2025Nov 4, 2025
$1.74vs $1.46-19.4%
$56Mvs $55M+3.2%
Q3 2025Aug 5, 2025
$1.24vs $1.84+32.6%
$71Mvs $61M+15.4%
Based on last 12 quarters of dataView full earnings history →

AMWL Peer Comparison

American Well Corporation (AMWL) competitors in Virtual Care and Digital Programs — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
TDOC logoTDOCTeladoc Health, Inc.Direct Competitor1.23B6.80-5.96-1.54%-6.81%-12.37%0.75
DOCS logoDOCSDoximity, Inc.Direct Competitor5.17B25.6923.1419.98%37.54%24.45%0.01
HIMS logoHIMSHims & Hers Health, Inc.Direct Competitor6.94B26.8852.7159%5.47%23.73%2.07
OPRX logoOPRXOptimizeRx CorporationDirect Competitor120.61M6.4723.9618.78%4.69%4.22%0.04
TALK logoTALKTalkspace, Inc.Product Competitor869.39M5.19129.7522%3.4%6.89%
CLOV logoCLOVClover Health Investments, Corp.Product Competitor1.37B2.68-15.7640.34%-2.58%-17.08%
GDRX logoGDRXGoodRx Holdings, Inc.Product Competitor880.73M2.5730.130.57%3.74%4.75%0.10
PRVA logoPRVAPrivia Health Group, Inc.Product Competitor3.01B23.99133.2822.26%1.08%3.06%0.01

Compare AMWL vs Peers

American Well Corporation (AMWL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TDOC

Most directly comparable listed peer for AMWL.

Scale Benchmark

vs WELL

Larger-name benchmark to compare AMWL against a more recognizable public peer.

Peer Set

Compare Top 5

vs TDOC, DOCS, HIMS, OPRX

AMWL Income Statement

American Well Corporation (AMWL) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue113.95M148.86M245.26M252.79M277.19M259.05M254.36M249.32M182.49M
Revenue Growth %-30.63%64.77%3.07%9.65%-6.55%-1.81%-1.98%-30.26%
Cost of Goods Sold58.61M79.98M156.79M148.47M160.42M164.29M155.41M116.47M111.81M
COGS % of Revenue51.43%53.73%63.93%58.73%57.87%63.42%61.1%46.71%-
Gross Profit
55.34M▲ 0%
68.88M▲ 24.5%
88.47M▲ 28.4%
104.31M▲ 17.9%
116.77M▲ 11.9%
94.76M▼ 18.8%
98.95M▲ 4.4%
132.86M▲ 34.3%
70.68M▲ 0%
Gross Margin %48.57%46.27%36.07%41.27%42.13%36.58%38.9%53.29%38.73%
Gross Profit Growth %-24.46%28.45%17.9%11.94%-18.85%4.42%34.27%-
Operating Expenses110.45M163.59M315.91M283.46M392.62M786.9M316.49M238.13M217.85M
OpEx % of Revenue96.92%109.89%128.8%112.13%141.64%303.77%124.42%95.51%-
Selling, General & Admin68.85M101.88M221.34M160.78M227.98M213.1M197.45M131.31M120.99M
SG&A % of Revenue60.42%68.44%90.25%63.6%82.25%82.27%77.62%52.67%-
Research & Development36.27M53.94M84.41M106.59M138.49M105.83M86.06M72.86M63.14M
R&D % of Revenue31.83%36.24%34.42%42.17%49.96%40.85%33.84%29.22%-
Other Operating Expenses5.33M7.76M10.15M16.09M26.15M467.97M32.98M33.96M4M
Operating Income
-55.11M▲ 0%
-94.7M▼ 71.9%
-227.43M▼ 140.1%
-179.15M▲ 21.2%
-275.85M▼ 54.0%
-692.14M▼ 150.9%
-217.53M▲ 68.6%
-105.27M▲ 51.6%
-92.29M▲ 0%
Operating Margin %-48.36%-63.62%-92.73%-70.87%-99.52%-267.19%-85.52%-42.22%-50.57%
Operating Income Growth %--71.86%-140.15%21.23%-53.98%-150.91%68.57%51.61%-
EBITDA-49.78M-86.94M-217.28M-163.06M-249.69M-660.63M-184.56M-71.31M-58.56M
EBITDA Margin %-43.68%-58.41%-88.59%-64.5%-90.08%-255.02%-72.56%-28.6%-32.09%
EBITDA Growth %--74.67%-149.91%24.95%-53.13%-164.58%72.06%61.36%58.28%
D&A (Non-Cash Add-back)5.33M7.76M10.15M16.09M26.17M31.51M32.98M33.96M33.72M
EBIT-55.11M-94.7M-227.43M-179.15M-275.85M-255.66M-217.53M-105.27M-74.86M
Net Interest Income2.79M5.54M1.63M120K6.12M19.42M10.76M3.8M1.48M
Interest Income2.79M5.54M1.63M120K6.12M19.42M10.76M3.8M1.48M
Interest Expense00000000313K
Other Income/Expense2.79M5.54M-556K-3.01M3.85M16.83M7.65M10.74M5.46M
Pretax Income
-52.31M▲ 0%
-89.17M▼ 70.5%
-227.99M▼ 155.7%
-182.16M▲ 20.1%
-272.01M▼ 49.3%
-675.31M▼ 148.3%
-209.89M▲ 68.9%
-94.53M▲ 55.0%
-86.83M▲ 0%
Pretax Margin %-45.91%-59.9%-92.96%-72.06%-98.13%-260.69%-82.51%-37.92%-47.58%
Income Tax0-803K639K-5.38M64K3.86M2.75M434K-351K
Effective Tax Rate %0%0.9%-0.28%2.95%-0.02%-0.57%-1.31%-0.46%0.4%
Net Income
-52.67M▲ 0%
-87.19M▼ 65.5%
-224.43M▼ 157.4%
-176.33M▲ 21.4%
-270.43M▼ 53.4%
-675.16M▼ 149.7%
-208.14M▲ 69.2%
-95.7M▲ 54.0%
-87.88M▲ 0%
Net Margin %-46.22%-58.57%-91.51%-69.76%-97.56%-260.63%-81.83%-38.38%-48.16%
Net Income Growth %--65.53%-157.41%21.43%-53.36%-149.66%69.17%54.02%43.21%
Net Income (Continuing)-52.31M-88.37M-228.63M-176.78M-272.07M-679.17M-212.64M-94.97M-87.5M
Discontinued Operations000000000
Minority Interest27.43M26.26M22.07M21.62M19.97M15.97M11.47M12.21M12.79M
EPS (Diluted)
-25.96▲ 0%
-42.39▼ 63.3%
-45.32▼ 6.9%
-13.88▲ 69.4%
-19.68▼ 41.8%
-47.50▼ 141.4%
-13.88▲ 70.8%
-5.96▲ 57.1%
-5.30▲ 0%
EPS Growth %--63.29%-6.91%69.37%-41.79%-141.36%70.78%57.06%46.81%
EPS (Basic)-25.96-42.39-45.32-13.88-19.68-47.50-13.88-5.96-
Diluted Shares Outstanding2.03M2.06M4.95M12.7M13.71M14.21M15M16.05M16.59M
Basic Shares Outstanding2.03M2.06M4.95M12.7M13.71M14.21M15M16.05M16.59M
Dividend Payout Ratio---------

AMWL Balance Sheet

American Well Corporation (AMWL) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets300.17M223.53M1.11B827.3M626.62M449.58M316.99M246.68M259.05M
Cash & Short-Term Investments256.2M177.63M1.04B746.42M538.55M372.04M228.32M182.33M179.21M
Cash Only47.98M137.67M941.62M746.42M538.55M372.04M228.32M182.33M179.21M
Short-Term Investments208.23M39.95M99.96M000000
Accounts Receivable30.78M32.73M45.3M51.38M58.37M54.15M71.89M49.69M57.09M
Days Sales Outstanding98.5880.2567.4174.1876.8676.29103.1572.75107.96
Inventory2.51M3.1M9.13M7.53M8.74M6.65M2.86M1.19M1.15M
Days Inventory Outstanding15.6414.1721.2518.5119.8814.786.713.725.18
Other Current Assets5.87M2.91M3.23M1.7M1.39M16.75M13.93M13.47M21.6M
Total Non-Current Assets189.15M276.35M263.36M618.54M590.94M140.12M118.97M77.11M66.92M
Property, Plant & Equipment3.08M14.61M10.45M18.66M14.52M11.03M7.58M4.16M178K
Fixed Asset Turnover37.03x10.19x23.48x13.55x19.09x23.50x33.56x60.01x47.95x
Goodwill127.27M193.88M193.88M442.76M435.28M0000
Intangible Assets55.39M63.53M55.53M152.41M134.98M120.25M101.54M66.07M61.09M
Long-Term Investments00752K168K795K1.18M1.5M795K3.38M
Other Non-Current Assets4.5M5.48M1.43M2.52M6.16M7.67M8.36M6.08M26.93M
Total Assets
489.31M▲ 0%
499.88M▲ 2.2%
1.38B▲ 175.4%
1.45B▲ 5.0%
1.22B▼ 15.8%
589.71M▼ 51.6%
435.97M▼ 26.1%
323.79M▼ 25.7%
325.97M▲ 0%
Asset Turnover0.23x0.30x0.18x0.17x0.23x0.44x0.58x0.77x0.52x
Asset Growth %-2.16%175.39%5.03%-15.79%-51.57%-26.07%-25.73%-97.07%
Total Current Liabilities87.83M106.58M120.98M141.63M114.06M93.8M111.26M73.21M83.77M
Accounts Payable4.23M6.5M5.8M12.16M7.24M4.86M5.01M1.65M1.39M
Days Payables Outstanding26.3229.6813.529.8816.4610.8111.785.1710.39
Short-Term Debt000000003.96M
Deferred Revenue (Current)64.13M00049.51M46.37M53.23M22.63M122.84M
Other Current Liabilities8.3M66.49M66.69M83.84M35.97M12.14M36.07M34.73M48.76M
Current Ratio3.42x2.10x9.20x5.84x5.49x4.79x2.85x3.37x3.37x
Quick Ratio3.39x2.07x9.13x5.79x5.42x4.72x2.82x3.35x3.35x
Cash Conversion Cycle87.9164.7475.1662.8180.2880.2698.0971.3102.75
Total Non-Current Liabilities605.89M18.37M9.47M43.34M19.65M15.72M8.46M2.79M2.07M
Long-Term Debt000000000
Capital Lease Obligations07.16M1.3M14.69M11.79M8.21M4.51M892K5.36M
Deferred Tax Liabilities000000000
Other Non-Current Liabilities576.72M11.21M64K21.59M1.57M1.43M1.17M1.07M5.68M
Total Liabilities693.72M124.95M130.45M184.96M133.71M109.52M119.72M76M85.84M
Total Debt013.4M7.65M16.61M14.84M11.79M8.2M4.52M3.96M
Net Debt-47.98M-124.28M-933.96M-729.8M-523.7M-360.25M-220.12M-177.8M-175.25M
Debt / Equity-0.04x0.01x0.01x0.01x0.02x0.03x0.02x0.02x
Debt / EBITDA---------0.07x
Net Debt / EBITDA--------2.99x
Interest Coverage---------239.18x
Total Equity
371.3M▲ 0%
374.94M▲ 1.0%
1.25B▲ 232.4%
1.26B▲ 1.2%
1.08B▼ 14.0%
480.19M▼ 55.7%
316.24M▼ 34.1%
247.79M▼ 21.6%
240.12M▲ 0%
Equity Growth %-0.98%232.38%1.18%-14.04%-55.7%-34.14%-21.65%-88.78%
Book Value per Share182.98182.28251.6499.2579.0433.7921.0815.4414.47
Total Shareholders' Equity343.87M348.68M1.22B1.24B1.06B464.22M304.77M235.58M227.33M
Common Stock49K423K2.36M2.62M2.77M145K156K165K167K
Retained Earnings-270.74M-357.93M-582.36M-811.28M-1.08B-1.76B-1.97B-2.06B-2.07B
Treasury Stock0-158K-37.57M000000
Accumulated OCI1.35M250K297K-6.35M-16.97M-15.65M-15.84M-12.1M-12.07M
Minority Interest27.43M26.26M22.07M21.62M19.97M15.97M11.47M12.21M12.79M

AMWL Cash Flow Statement

American Well Corporation (AMWL) cash flow — operating, investing & free cash flow history

Line itemDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations-74.01M-81.89M-112.46M-141.54M-192.32M-148.34M-127.34M-65.95M-65.95M
Operating CF Margin %-64.94%-55.01%-45.85%-55.99%-69.38%-57.26%-50.06%-26.45%-
Operating CF Growth %--10.66%-37.33%-25.85%-35.88%22.87%14.16%48.21%187.23%
Net Income-52.31M-88.37M-228.63M-176.78M-272.07M-675.16M-208.14M-95.7M-87.88M
Depreciation & Amortization5.33M7.76M10.15M16.09M26.17M31.92M33.43M33.96M34.69M
Stock-Based Compensation7.67M12.13M118.36M43.81M67.67M72.25M022.01M16.98M
Deferred Taxes884K-1.39M3.83M-6.25M-2.52M-242K-243K-1.11M-39K
Other Non-Cash Items1.19M2.49M2.26M9.31M16.53M438.4M57.59M1.68M7.27M
Working Capital Changes-36.77M-14.52M-18.45M-27.71M-28.1M-15.51M-9.98M-26.8M-14.06M
Change in Receivables-19.47M803K-14.21M-512K-8.14M3.25M-25.01M12.22M9.89M
Change in Inventory1.57M-592K-6.02M1.6M-1.21M2.08M1.9M1.17M882K
Change in Payables-787K1.16M-707K5.55M-4.78M-2.36M159K-3.42M-5.11M
Cash from Investing-245.93M120M-66.76M-59.63M-11.63M-19.17M-18.65M17.1M-5.07M
Capital Expenditures-1.91M-1.34M-3.32M-559K-10.45M-292K0-21K-17K
CapEx % of Revenue1.68%0.9%1.35%0.22%3.77%0.11%5.98%0.01%-
Acquisitions-64.38M-45.75M-2.94M-159.07M-1.96M0018.32M-2.08M
Investments---------
Other Investing000-2.55M0-18.88M-18.65M-196K-2.78M
Cash from Financing278.18M46.64M983.12M5.75M-3.61M2.15M1.38M840K600K
Debt Issued (Net)000000000
Equity Issued (Net)277.55M45.6M980.48M-15.04M-360K-586K-3K840K297K
Dividends Paid000000000
Share Repurchases-2.9M-158K-37.57M-15.04M-360K-586K-3K-4K-3K
Other Financing635K1.04M2.64M20.79M-3.25M2.73M1.38M0303K
Net Change in Cash
-41.76M▲ 0%
84.75M▲ 302.9%
803.89M▲ 848.6%
-195.5M▼ 124.3%
-207.87M▼ 6.3%
-166.51M▲ 19.9%
-143.72M▲ 13.7%
-45.99M▲ 68.0%
-43.2M▲ 0%
Free Cash Flow
-75.92M▲ 0%
-83.23M▼ 9.6%
-115.78M▼ 39.1%
-142.1M▼ 22.7%
-202.77M▼ 42.7%
-163.59M▲ 19.3%
-142.56M▲ 12.9%
-65.97M▲ 53.7%
-41.84M▲ 0%
FCF Margin %-66.62%-55.91%-47.21%-56.21%-73.15%-63.15%-56.05%-26.46%-22.93%
FCF Growth %--9.63%-39.11%-22.73%-42.7%19.32%12.86%53.72%60.16%
FCF per Share-37.41-40.46-23.38-11.19-14.79-11.51-9.50-4.11-4.11
FCF Conversion (FCF/Net Income)1.40x0.94x0.50x0.80x0.71x0.22x0.61x0.69x0.48x
Interest Paid000000000
Taxes Paid0193K713K1.59M1.72M5M4.11M0686K

AMWL Key Ratios

American Well Corporation (AMWL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2019202020212022202320242025TTM
Return on Equity (ROE)-23.37%-27.69%-14.07%-23.07%-86.34%-52.27%-33.93%-33.48%
Return on Invested Capital (ROIC)-24.75%-60.61%-31.86%-37.92%-152.66%-151.02%-95.06%-95.06%
Gross Margin46.27%36.07%41.27%42.13%36.58%38.9%53.29%38.73%
Net Margin-58.57%-91.51%-69.76%-97.56%-260.63%-81.83%-38.38%-48.16%
Debt / Equity0.04x0.01x0.01x0.01x0.02x0.03x0.02x0.02x
Interest Coverage--------239.18x
FCF Conversion0.94x0.50x0.80x0.71x0.22x0.61x0.69x0.48x
Revenue Growth30.63%64.77%3.07%9.65%-6.55%-1.81%-1.98%-30.26%

AMWL SEC Filings & Documents

American Well Corporation (AMWL) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Apr 2, 2026·SEC

Material company update

Feb 12, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 12, 2026·SEC

FY 2025

Feb 12, 2025·SEC

FY 2024

Feb 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 5, 2025·SEC

AMWL Frequently Asked Questions

American Well Corporation (AMWL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

American Well Corporation (AMWL) reported $182.5M in revenue for fiscal year 2025. This represents a 60% increase from $114.0M in 2018.

American Well Corporation (AMWL) saw revenue decline by 2.0% over the past year.

American Well Corporation (AMWL) reported a net loss of $87.9M for fiscal year 2025.

Dividend & Returns

American Well Corporation (AMWL) has a return on equity (ROE) of -33.9%. Negative ROE indicates the company is unprofitable.

American Well Corporation (AMWL) had negative free cash flow of $41.8M in fiscal year 2025, likely due to heavy capital investments.

Explore More AMWL

American Well Corporation (AMWL) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.